What Trophic Communications does

Trophic Communications GmbH is a Munich-headquartered, privately held strategic communications and investor relations agency founded in December 2017 by Gretchen Schweitzer. The firm exclusively serves biotech and life science companies, ranging from early-stage start-ups through publicly listed biopharmaceutical leaders, with documented experience supporting European and US NASDAQ IPOs. Services are delivered through a multidisciplinary team of approximately 20+ staff combining scientific credentials (PhDs in neuroscience, biochemistry, molecular biology, and pharmaceutical sciences) with specialized communications experience drawn from prior roles at MD Anderson Cancer Center, Max Planck Institute, Feinstein Kean Healthcare, Argot Partners, and Amazon.

The company operates three core service lines: Public Relations (media relations, crisis communications, social media strategy, event support), Investor Relations (financial communications, IPO preparation, peer analysis, roadshow planning, conference support, presentation training), and Strategic Materials (scientific posters, websites, brand identity, mechanism-of-action visuals, corporate Q&A, and presentation development). Case-study validated offerings in Positioning, Visibility, and US Market Recognition address specific client needs around corporate identity and transatlantic capital markets visibility. The business model is B2B professional services with engagements negotiated directly with C-level executives and management teams; no pricing is publicly disclosed.

Customers are based across 20+ countries in Europe and North America. The firm is founder-owned, reports no institutional investors, funding rounds, or parent company, and shows no acquisition activity. Recent directional signals include a 2026 hiring wave adding four Account Executives, a Head of HR, and an Office Manager, and the 2024 hire of Anja Heuer specifically to deepen Nasdaq IPO communications capability. The company does not develop technology products and explicitly excludes AI from its hiring and core service delivery.

Name

Trophic Communications

Legal name

Trophic Communications GmbH

Website

https://trophic.eu

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Trophic Communications is a Munich-based strategic communications and investor relations agency founded in 2017, serving biotech and life science companies from early-stage start-ups to publicly listed biopharmaceuticals with PR, IR, and strategic materials services across Europe and North America.

Ownership category

akta.pro rank

Product category

Biotech Communications and Investor Relations Services

NAICS

Public Relations Agencies (54182)

SIC

Services-Advertising Agencies (7311)

akta.pro primary industry

Event Content Marketing, PR & Media Outreach (THAHAGAG)

akta.pro secondary industries

Litigation PR & Legal Communications (MPAAAOAH), Incident Management, Alerts & Crisis Communications (THACANAD)

Keywords

• Biotech public relations
• Investor relations services
• Life science communications
• Strategic communications agency
• Biotech IPO advisory

Headquarters

HQ city

Munich

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Professional Services - Communications Consulting: Revenue generated through providing strategic communications, public relations, and investor relations services to biotech and life science companies. Services include media outreach, thought leadership content, IPO preparation, roadshow support, and crisis communications.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Trophic Communications is a strategic communications and investor relations agency that delivers public relations, investor relations, and strategic materials services to biotech and life science companies. Its offerings include media engagement, thought-leadership content, IPO readiness and roadshow support, crisis communications, and the creation of tailored materials such as websites, scientific posters, and social media assets.

Product overview

Trophic Communications offers a unified communications and investor relations service portfolio for life science companies, comprising three core service areas: Public Relations (press releases, media relations, crisis communications, conferences, social media, events), Investor Relations (financial communications, IPO preparation, peer analysis, roadshows, conference support, presentation training), and Strategic Materials (scientific posters, websites, branding, mechanisms of action visuals, Q&As, presentations). The company also provides specialized case-study validated offerings in Positioning, Visibility, and US Market Recognition to support biotech companies at various stages from seed funding through IPO.

Differentiator

Problem solved

Functional benefit

Products and services

• Public Relations Services Communications services including press releases, media relations and outreach, crisis communications, conference and meetings support, social media strategy, and event planning, designed to build visibility and credibility for life science companies through strategic media engagement, expert-driven content, and thought leadership.
• Investor Relations Services Financial communications, IPO preparation support, peer analysis, roadshow planning and support, financial conference support, and corporate presentation training for biotech and life science companies. The program is designed to build long-term trust and market visibility through tailored engagement with investors and analysts.
• Strategic Materials Services Creation of scientific posters, website development and updates, logo and brand development, mechanisms of action visuals, corporate Q&A preparation, and corporate presentation development and updates, designed to maximize reach and impact across channels.
• US Recognition Services Specialized services helping European biotech companies establish visibility in the US market ahead of Nasdaq IPOs, including media outreach, positioning, social media strategy, website and corporate video development, and IPO readiness preparation.
• Visibility Services Media coverage and messaging services including PR programs, media outreach, and media training to increase visibility among investors, financial community, and potential partners for biotech and life science companies.
• Positioning Services Corporate identity development including core messaging definition, differentiation strategy, competitor landscape analysis, brand identity creation, and website development for biotech company launches and strategic communications.

Quantifiable outcome

• Achieved high levels of media attention from prominent US and global biotech and financial publications for a German biotech client ahead of Nasdaq IPO
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Real Chemistry: Large healthcare and life sciences marketing, PR, and communications firm serving biotech, pharma, and health-tech clients globally. Comparable to Trophic's scientific communications focus but operates at much greater scale and across a broader healthcare communications portfolio.
• ICR (formerly Westwicke): Large strategic communications and advisory firm with a substantial healthcare and biotech IR/PR practice. Comparable to Trophic on biotech IR and IPO communications but at meaningfully larger scale and broader service breadth.

Direct peers

• Russo Partners: Specialist life sciences and healthcare public relations and investor relations firm with offices in New York and California. Comparable to Trophic in delivering senior-led, science-literate PR and IR support to biotech clients at clinical and capital-markets milestones.
• MacDougall Biomedical Communications: Specialist PR firm serving life sciences clients, founded by the same individual who founded Trophic. Direct comparability on vertical, service mix, and senior team lineage, though it operates as the predecessor US-affiliated agency.
• LaVoieHealthScience: Boston-based integrated PR, investor relations and digital communications agency focused on biotech, pharma, and healthtech. Directly comparable to Trophic in serving life sciences clients across the full PR-to-IR spectrum, especially around IPO readiness and US capital markets.
• Canale Communications: San Diego-based life sciences communications agency providing public relations, investor relations, and corporate communications to biotech and pharma clients. Closely mirrors Trophic's integrated PR/IR offering and biotech-only vertical focus.
• Argot Partners: Investor relations and public relations agency specialized in life sciences, with deep expertise in biotech IR, earnings, and IPO communications. Senior Advisor Joe Rayne's prior affiliation highlights direct comparability to Trophic's IR offering.
• LifeSci Communications: New York-based public relations and investor relations firm dedicated to the life sciences industry. Overlaps directly with Trophic on PR, IR, and strategic communications for biotech and pharma clients across early-stage and public company stages.
• Feinstein Kean Healthcare: Long-standing life sciences communications consultancy where Trophic's founder cut her teeth leading the entire Corporate Practice. Directly comparable on biotech and pharma PR/IR depth and consultancy model.

Emerging players

• JPA Health: Full-service public relations and marketing agency with a life sciences practice covering biotech, pharma, and patient advocacy. Comparable to Trophic for scientific storytelling and patient/community communications but with a broader marketing scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/trophic-communications
• Xx.com/TrophicComms

Revenue estimate

Valuation estimate

Number of profiles

Profiles19 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Trophic Communications